Bloomberg reports that a Missouri appeals court has reduced Johnson & Johnson’s (JNJ -0.3%) $4.7B talcum powder verdict to $2.1B.
The company appealed the 2018 state court verdict
awarding 22 women with ovarian cancer $4.69B. Six died before the trial
started and five since it ended. It still faces talcum powder-related
lawsuits from more than 19K plaintiffs.
Last month, the company announced that it would stop selling talc-containing baby powder in the U.S. and Canada citing diminished demand amid safety concerns.
https://seekingalpha.com/news/3585391-court-cuts-j-and-j-talc-verdict-to-2_1b
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.